Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Treating chronic pain: Regulation ignores the larger issues

Shirie Leng, MD
Meds
December 23, 2014
Share
Tweet
Share

Doctors have a long and illustrious history of addicting people to narcotics.  In the 1800s this was largely because they didn’t know what else to do, they had no idea what was wrong with anyone, and they didn’t have any drugs that worked.  Apothecaries, pharmacists, and doctors made proprietary concoctions in which opium was always the active ingredient.

And it worked, right?  Morphine works for anxiety, works for pain, works for “fluxes.”  What else could really be wrong with people anyway?  This profligate use of narcotics had it’s expected effect.  Thomas Crothers, in 1902, wrote a book called Morphinism and Narcomanias from Other Drugs.

“Morphinism,” Crothers explained,  “is a condition following the prolonged use of morphine by needle or mouth.  Women, especially, are affected by it.  Capriciousness, irritability, selfishness, and excitability are the natural characteristics of women who are morphinists.  Morphinomania is the condition of persons in which the impulse to use morphine is dominating.  Such a person is often a psychopath from heredity and has a defective neurotic organization.  Morphinomania is a moral disorder.  Even if no immediate deleterious effect is in evidence, the will, and moral forces suffer.”

Something had to be done about these amoral, mostly female, degenerates, clearly.  In the 1860s states started passing laws that said that the potions being made at least had to have an ingredient label.  The Pure Food and Drugs Act of 1906 was the beginning of the FDA, so named in 1930, but even then narcotics were available, as long as they were labeled.  But it helped.  In an effort to regulate narcotics, the Controlled Substance Act was signed into law in 1970, creating the schedule system we know today.

Other early interventions basically amounted to warning labels.  In 2005 The DEA, in an effort to increase detox and treatment, allowed practitioners who were not formally in the drug treatment business to use other scheduled drugs to treat addiction.  In 2007 the FDA got a new tool, Risk Evaluation and Mitigation Strategies (REMS), that allowed them to put restrictions on certain substances.   In 2009, the FDA asked for recommendations on restricting prescribing which were met with opposition from drug companies and physicians’ lobbying groups.

 

Last year, the FDA recommended changing hydrocodone-containing drugs to Schedule II (highly addictive) and limiting refills and prescribing practices.  Still the epidemic goes on.

Dr. Thomas Frieden, director of the Centers for Disease Control, made the following comment about prescription drug abuse: “This is an epidemic that was caused largely by inappropriate prescribing, and it can be fixed to a significant extent by improving prescribing.”

I used to take umbrage at this kind of remark.  After all, doctors cannot be responsible for what people put in their mouths.

Then I read about Florida.  Did you know that doctors in Florida bought 89 percent of the oxycodone sold in the entire country in 2010? 98 of the 100 highest prescribers of narcotics practiced in Florida. The pain clinics lined the streets.  No wonder trust in physicians is at an all-time low.  There is absolutely no excuse for the behavior of these physicians.

Here’s what Florida did, starting in 2010.  They made pain clinics register with the state.  They indicted “pill mill” owners and, in once case, accused a doctor of murder.  Doctors’ licenses got suspended.  A prescription drug monitoring system was put in place, privately funded since Florida Republicans blocked the measure in the state legislature.  And it worked.  Prescription drug overdose deaths are down 23 percent.  Doctors’ purchases of oxycodone fell by 97 percent.

What is the problem here?  A few physicians violating the Hippocratic and every other oath I can think of?  Oh, yes.  Doctors and pill mill owners should absolutely be prosecuted to the full extent of the law.  But, as I pointed out above, addiction is an old disease.  Some of the Florida patients who can’t get prescription narcotics anymore will go to heroin or cocaine.  Some will get morphine instead.  Some will seek rehab treatment.

The larger issue, however, is addiction itself.  The social, genetic, behavioral, and neurochemical drives for drug use are powerful, persistent, and ancient.  We can choose to criminalize drug use, declare it a disease and treat it, ignore it, or feed it.  What we do with it, as a society, will be one of the things that define us for future generations and civilizations.

Shirie Leng, a former nurse, is an anesthesiologist who blogs at medicine for real.

ADVERTISEMENT

Prev

Enduring the night of a never-ending ER shift

December 23, 2014 Kevin 1
…
Next

An ER patient that stirs every emotion

December 24, 2014 Kevin 1
…

Tagged as: Medications, Pain Management

Post navigation

< Previous Post
Enduring the night of a never-ending ER shift
Next Post >
An ER patient that stirs every emotion

ADVERTISEMENT

More by Shirie Leng, MD

  • The choice between medicine and nursing

    Shirie Leng, MD
  • New technology might help us become more empathetic to others’ suffering

    Shirie Leng, MD
  • Does practice really make perfect?

    Shirie Leng, MD

More in Meds

  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • Most Popular

  • Past Week

    • The mental health workforce is collapsing

      Ronke Lawal | Conditions
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
    • The infectious hypothesis of heart disease revisited

      Larry Kaskel, MD | Conditions
    • A nurse practitioner on leaving the medical machine

      Carrie Friedman, NP | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
  • Recent Posts

    • The infectious hypothesis of heart disease revisited

      Larry Kaskel, MD | Conditions
    • Why bureaucracy is threatening the survival of private practice physicians [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why direct primary care (DPC) models fail

      Dana Y. Lujan, MBA | Policy
    • The silent victories of medicine

      Dr. Bodhibrata Banerjee | Physician
    • How timing affects chemical exposure risks

      Oluyemisi Famuyiwa, MD | Conditions
    • A physician’s tribute to respiratory therapists

      Zoran Naumovski, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 13 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The mental health workforce is collapsing

      Ronke Lawal | Conditions
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
    • The infectious hypothesis of heart disease revisited

      Larry Kaskel, MD | Conditions
    • A nurse practitioner on leaving the medical machine

      Carrie Friedman, NP | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
  • Recent Posts

    • The infectious hypothesis of heart disease revisited

      Larry Kaskel, MD | Conditions
    • Why bureaucracy is threatening the survival of private practice physicians [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why direct primary care (DPC) models fail

      Dana Y. Lujan, MBA | Policy
    • The silent victories of medicine

      Dr. Bodhibrata Banerjee | Physician
    • How timing affects chemical exposure risks

      Oluyemisi Famuyiwa, MD | Conditions
    • A physician’s tribute to respiratory therapists

      Zoran Naumovski, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Treating chronic pain: Regulation ignores the larger issues
13 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...